Navigation Links
NutraCea Appoints New Chief Financial Officer
Date:3/17/2008

PHOENIX, March 17 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB), nutrient research and technology, today announced that Todd Crow will step down from his role as Chief Financial Officer on March 31, 2008 and that Ken A. Mueller (55) will assume the role of Chief Financial Officer on that date. Mr. Crow has agreed to stay on as a consultant to ensure a smooth transition of his responsibilities to Mr. Mueller.

Mr. Mueller has over 20 years of expertise in working with private and Fortune 100 companies. He has extensive knowledge in strategic planning, international operations, and investor relations. During the course of his career he has helped take several organizations (listed below) to their next level of growth and profitability.

"We are extremely pleased to have Ken join our organization. His proven ability to work with management as they look to rapidly grow their business will be most valuable to us as we position NutraCea for its next stage of growth," said Brad Edson, President of NutraCea. "Ken's appointment will help to promote the successful implementation of our strategic growth plan."

Mr. Edson added, "We also want to thank Todd Crow for his contributions to NutraCea during his tenure and know that the transition will go smoothly under his guidance."

Most recently, Mueller was chief financial officer of Collins Financial Services where he served as a strategic partner to the company developing and implementing the financial plans to meet aggressive growth goals over the last two years.

Prior to his work with Collins, Mr. Mueller was the chief financial officer of SafeNet Corporation. He also previously served as the Chief Financial Officer of Microsoft Business Solutions and Senior Vice President of finance at Platinum Technology, which was ultimately acquired by Computer Associates.

Early in his career, Mueller served in various capacities at
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. NutraCea Announces Conference Call to Report Second Quarter Financial Results
4. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
5. NutraCea Provides Update on Domestic Operations
6. NutraCea Files Universal Shelf Registration Statement
7. NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America
8. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
9. WorldHeart Appoints David Pellone Chief Financial Officer
10. Novo Nordisk Appoints New Leader of North American Business
11. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...class of drugs based on a widely used anticancer d...g effects in the laboratory and in mice, according... interesting for the treatment of these tumors. //...rea were extremely active in blocking the same cel...
... Cipro, Cipro. That's been the mantra of the media...usands who weren't -- clamor for the potent antibi...r cheaper and widely available medications can be ...rug: penicillin. Although alternatives exist, Cipr...
...erimental anti-cancer drug has shown effectiveness...ng to a new report. Researchers say the drug proba...be useful for treating other types of cancer. Dr. ...Bethesda, Maryland, and colleagues tested the drug...
...ox, a highly contagious virus that kills at least ...survive, was eradicated from the globe more than t...variola virus, which causes the disease, and store..., and Moscow, Russia. A smallpox attack is just on...
Other Medicine News:
(Date:9/3/2008)...Wrong Children Studied. Wrong,Conclusions Reached.... Centers for Disease,Control and Prevention (CDC) ...en the MMR vaccine and autism. The National Autism... dispel the growing public concern over a,vaccine-...cerning design,and methodology., For years, paren...
(Date:9/3/2008)...scular Disease Awareness Month, CHARLOTTESVILLE, ...cals,LLC, a clinical-stage drug-development compan...nmet medical needs, announced today that it has be...ial of its lead drug,candidate trans sodium crocet...the clinicaltrials.gov Website, is investigating T...
(Date:9/3/2008)... Phase 3 Plans with FDA, PRINCETON, N.J., Sept. 3...ed today that it successfully completed two key cl...new, innovative low-dose, once-weekly,contracepti...nal product,code AG-200-15. The Phase 2b safety an...oint of ovulation suppression, cycle control and s...
(Date:9/3/2008)...swire-FirstCall/ -- A sub-analysis of,the TRITON-T...rasugrel,compared with clopidogrel significantly r...(7.4 percent vs. 9.7 percent, p<0.0001), regardles...f an artery-opening,procedure known as percutaneou... spontaneously during the longer-term maintenance ...
Breaking Medicine Technology:CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Biannual Antibiotics May Cut Major Cause of Blindness in Africa 12290 1Biannual Antibiotics May Cut Major Cause of Blindness in Africa 12290 2NIST NCI SAIC partner on new method for detecting HER2 breast cancer 12288 1NIST NCI SAIC partner on new method for detecting HER2 breast cancer 12288 2DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 1DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 2DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 3XTENT Announces 2007 Financial Results 12282 1XTENT Announces 2007 Financial Results 12282 2XTENT Announces 2007 Financial Results 12282 3XTENT Announces 2007 Financial Results 12282 4XTENT Announces 2007 Financial Results 12282 5XTENT Announces 2007 Financial Results 12282 6
....--(BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,Sci... today,statistically significant results with BEMA... pain in its pivotal Phase III efficacy,clinical t...ievement of the primary efficacy endpoint of the t... compared to placebo., The results demonstrated th...
...mark; April 25, 2007 - Genmab A/S (CSE: GEN),annou...th,ofatumumab (HuMax-CD20™) in patients with...oral presentation at the 2007,Annual European Cong...n, which will include new results from the double-...umumab, along with data,from the previous interim ...
Other Medicine Technology:BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6
Tank Blotting System. Designed for Western, Northern, or Southern Blotting. Transfer up to three gels with dimensions as large as 15cm x 21.5cm. Includes and internal cooling base for temperature
... proven electrophoretic transfer apparatus incorpo...ltimate in field uniformity. Its design allows for... when coupled with a low voltage power source such...ts/cm. The result is exceptionally rapid and exact...
...lot cell, a component of Bio-Rad's modular mini el...resis Systems), provides rapid, high-quality blott...ransfers two 7.5 x 10 cm gels in just 1 hour. Cool... absorbs heat generated during transfers. The Mini...
Includes PowerPac 200 power supply. Flexibility for a Range of Parameters. Quantitative Transfers. Native Enzyme, High Intensity, or Overnight Transfers. Faster, Higher-Efficiency Transfers via Pl
Medicine Products: